Newsletter | December 23, 2024

12.23.24 -- Optimism For Life Sciences Growth Amid Policy Shifts In 2025

FEATURED ARTICLE

Optimism For Life Sciences Growth Amid Policy Shifts In 2025

EY's Arda Ural provides an assessment of the current life sciences business environment, and reasons for optimism about 2025 despite the uncertainty that comes with a new administration in the U.S.

INDUSTRY INSIGHTS

All Biopharma Roads Begin With Eco-Design: How Can You Get Started?

Listen to a discussion between Ryan Walker, Cytiva, and Aude Arkam, Sanofi, to learn how the influence of eco-design can guide sustainability in the biopharma industry.

The Critical Role Of The Medical Monitor

Medical Monitors interact with nearly all functional roles on a study team and more experienced monitors often support and mentor less-experienced colleagues.

The Real Story Behind Gen AI Development In Clinical Trial Ops

As Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.

The Rapid Digitization Of Trials

It’s no secret that more trials are going digital. Hear from a panel of industry experts as they discuss the evolution of digital trials and share their experiences.

Bioconjugates – A Blossoming Of Therapeutic Applications

Harness the power of bioconjugation to revolutionize targeted therapies, enhance drug efficacy, and reduce side effects for more precise and effective treatments across a range of diseases.

A Hotbed For Life Sciences: Middlesex County's Unique Value Proposition

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.